| Mr Parsha Forouzan, MD | |
|
9955 Gillespie Dr, Suite 100, Plano, TX 75025 | |
| (972) 403-1110 | |
| (972) 403-1153 |
| Full Name | Mr Parsha Forouzan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 7 Years |
| Location | 9955 Gillespie Dr, Plano, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912433046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | T0479 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brooks Eye Associates Pllc | 9234384108 | 5 |
News Archive
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
› Verified 7 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
› Verified 7 days ago
| Entity Name | Brooks Eye Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285970467 PECOS PAC ID: 9234384108 Enrollment ID: O20130226000081 |
News Archive
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
› Verified 7 days ago
| Entity Name | Surgery Center 121 Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1093295545 PECOS PAC ID: 4486998069 Enrollment ID: O20181208000328 |
News Archive
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Parsha Forouzan, MD 9955 Gillespie Dr, Suite 100, Plano, TX 75025 Ph: (972) 403-1110 | Mr Parsha Forouzan, MD 9955 Gillespie Dr, Suite 100, Plano, TX 75025 Ph: (972) 403-1110 |
News Archive
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
› Verified 7 days ago
Dr. Yasser Elshatory, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3900 American Dr Ste 103, Plano, TX 75075 Phone: 972-427-4345 | |
Dr. Abdulfatah M Ali, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4108 West 15th St., Suite 200, Plano, TX 75075 Phone: 972-379-3937 Fax: 972-379-3938 | |
Dr. James A Passmore, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4100 West 15th Street, Suite 210, Plano, TX 75093 Phone: 972-867-7777 Fax: 972-519-1679 | |
Matthew Kenneth Adams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6843 Communications Pkwy Ste 810, Plano, TX 75024 Phone: 972-440-2020 Fax: 469-409-0595 | |
Dr. Ellen Ngo, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4100 W 15th St, Suite 210, Plano, TX 75093 Phone: 972-867-7777 Fax: 972-519-1679 | |
David R Stager Sr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3801 W 15th St, A-110, Plano, TX 75075 Phone: 214-281-1878 Fax: 972-964-5725 | |
Dr. David Lu, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1201 N Central Expy, Plano, TX 75075 Phone: 972-424-5811 |